Extracellular Vesicles: The Next Generation of Biomarkers and Treatment for Central Nervous System Diseases
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137371 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Gabriele Zanirati und 10 weiteren Autor:innen. Beteiligte Einrichtung: Brain Institute of Rio Grande do Sul (BraIns), Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre 90610-000, RS, Brazil. Hauptthemen laut MEDLINE: Extracellular Vesicles, Biomarkers, Central Nervous System Diseases. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 249 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
It has been widely established that the characterization of extracellular vesicles (EVs), particularly small EVs (sEVs), shed by different cell types into biofluids, helps to identify biomarkers and therapeutic targets in neurological and neurodegenerative diseases. Recent studies are also exploring the efficacy of mesenchymal stem cell-derived extracellular vesicles naturally enriched with therapeutic microRNAs and proteins for treating various diseases. In addition, EVs released by various neural cells play a crucial function in the modulation of signal transmission in the brain in physiological conditions. However, in pathological conditions, such EVs can facilitate the spread of pathological proteins from one brain region to the other. On the other hand, the analysis of EVs in biofluids can identify sensitive biomarkers for diagnosis, prognosis, and disease progression. This review discusses the potential therapeutic use of stem cell-derived EVs in several central nervous system diseases. It lists their differences and similarities and confers various studies exploring EVs as biomarkers. Further advances in EV research in the coming years will likely lead to the routine use of EVs in therapeutic settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain Institute of Rio Grande do Sul (BraIns), Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre 90610-000, RS, Brazil.
- Institute for Regenerative Medicine, Department of Cell Biology and Genetics, Texas A&M University School of Medicine, College Station, TX 77807, USA.
ORCID-Profile: Isadora Machado Ghilardi, Jaderson Costa da Costa
Förderung
- NIA NIH HHS
- NINDS NIH HHS
Zitieren
APA
Zanirati, G., Dos Santos, P. G., Alcará, A. M., Bruzzo, F., Ghilardi, I. M., Wietholter, V., Xavier, F. A. C., Gonçalves, J. I. B., Marinowic, D., Shetty, A. K., & da Costa, J. C. (2024). Extracellular Vesicles: The Next Generation of Biomarkers and Treatment for Central Nervous System Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137371
Vancouver
Zanirati G, Dos Santos PG, Alcará AM, Bruzzo F, Ghilardi IM, Wietholter V, et al. Extracellular Vesicles: The Next Generation of Biomarkers and Treatment for Central Nervous System Diseases. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137371
BibTeX
@article{Zanirati2024,
author = {Zanirati, Gabriele and Dos Santos, Paula Gabrielli and Alcará, Allan Marinho and Bruzzo, Fernanda and Ghilardi, Isadora Machado and Wietholter, Vinicius and Xavier, Fernando Antônio Costa and Gonçalves, João Ismael Budelon and Marinowic, Daniel and Shetty, Ashok K and da Costa, Jaderson Costa},
title = {Extracellular Vesicles: The Next Generation of Biomarkers and Treatment for Central Nervous System Diseases},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137371}
}
EUVIMED